{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:49:41Z","timestamp":1774936181629,"version":"3.50.1"},"reference-count":31,"publisher":"Bentham Science Publishers Ltd.","issue":"22","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Prostate and pancreatic cancers pose significant global health challenges.\nThis study explored the potential of compound 5b, a novel phthalimido-1,3-thiazole derivative, as\nan anticancer agent against these malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In vitro, compound 5b exhibited potent cytotoxic activity against both prostate (DU-145\nand PC-3) and pancreatic (Panc-1 and Mia Paca-2) cancer cell lines. Notably, it significantly reduced\ncolony formation in PC-3 cells, potentially hindering tumor growth. Furthermore, treatment\nwith compound 5b suppressed cell migration and induced cell cycle arrest in the PC-3 line. Additionally,\nit triggered cell death through late apoptosis and necrosis at higher concentrations. Safety\nevaluations in mice revealed no mortality or adverse effects after a 30-day treatment with compound\n5b. Key blood parameters (hematology) and biochemical markers of liver and kidney function\nremained unaltered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Compound 5b significantly reduced colony formation, suppressed cell migration, and\ninduced cell cycle arrest and apoptosis\/necrosis in prostate cancer cells. In vivo, safety evaluations\nshowed no adverse effects in treated mice, with blood and biochemical markers remaining normal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings suggest that compound 5b holds promise for further development as a\ntherapeutic option for prostate and pancreatic cancers. Its multimodal activity profile, targeting cell\nviability, migration, cell cycle progression, and cell death, warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115680266351687250309020134","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T02:41:58Z","timestamp":1742438518000},"page":"2655-2665","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal Activity of a Novel Compound against Prostate and Pancreatic Cancer"],"prefix":"10.2174","volume":"25","author":[{"given":"Flaviana Alves","family":"dos Santos","sequence":"first","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-1299","authenticated-orcid":true,"given":"Joelson","family":"Germano Crispim","sequence":"additional","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Davi Lima","family":"da Silva","sequence":"additional","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ars\u00eanio","family":"Rodrigues Oliveira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Planejamento em Qu\u00edmica Medicinal (LpQM), Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco, 50740-520, Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldilane Goncalves","family":"da Fonseca","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Laboratory and Multidisciplinary Laboratory, Federal University of Rio Grande do Norte, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Telma Maria Araujo","family":"Moura Lemos","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Laboratory and Multidisciplinary Laboratory, Federal University of Rio Grande do Norte, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-2292","authenticated-orcid":true,"given":"Ana Cristina Lima","family":"Leite","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Planejamento em Qu\u00edmica Medicinal (LpQM), Departamento de Ci\u00eancias Farmac\u00eauticas, Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Pernambuco, 50740-520, Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0163-3833","authenticated-orcid":true,"given":"Michelle Melgarejo","family":"da Rosa","sequence":"additional","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5881-0338","authenticated-orcid":true,"given":"Maira Galdino","family":"da Rocha Pitta","sequence":"additional","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1672-8202","authenticated-orcid":true,"given":"Michelly","family":"Cristiny Pereira","sequence":"additional","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"da Rocha Pitta","sequence":"additional","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moacyr Jesus Barreto","family":"de Melo R\u00eago","sequence":"additional","affiliation":[{"name":"Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE),Recife, PE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"Matthews H.K.","year":"2022","unstructured":"Matthews H.K.; Bertoli C.; de Bruin R.A.M.; Cell cycle control in cancer. Nat Rev Mol Cell Biol  2022,23(1),74-88","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1109\/ICCV51070.2023.01950","author":"Chen J.","unstructured":"Chen J.; Xia Y.; Yao J.; Yan K.; Zhang J.; Lu L.; Wang F.; Zhou B.; Qiu M.; Yu Q.; Yuan M.; Fang W.; Tang Y.; Xu M.; Zhou J.; Zhao Y.; Wang Q.; Ye X.; Yin X.; Shi Y.; Chen X.; Zhou J.; Yuille A.; Liu Z.; Zhang L.; CancerUniT: Towards a Single Unified Model for Effective Detection, Segmentation, and Diagnosis of Eight Major Cancers Using a Large Collection of CT Scans. Proceedings of the 2023 IEEE\/CVF International Conference on Computer Vision (ICCV),  Paris, France, 2023, pp. 21270-21281","journal-title":"Proceedings of the 2023 IEEE\/CVF International Conference on Computer Vision (ICCV),"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0043-1762925","volume":"45","author":"Pereira Primo1 W.Q.S.","year":"2023","unstructured":"Pereira Primo1 W.Q.S.; Estimated 2023: Cancer incidence in Brazil. Rev Bras Ginecol Obstet  2023,45(1),1-2","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1002\/cam4.5133","volume":"12","author":"Gbolahan O.","year":"2023","unstructured":"Gbolahan O.; Hashemi-Sadraei N.; Yash S.; Williams G.; Ramachandran R.; Kim Y.; Paluri R.; Outlaw D.; El-Rayes B.; Nabell L.; Time to treatment initiation and its impact on real\u2010world survival in metastatic colorectal cancer and pancreatic cancer. Cancer Med  2023,12(3),3488-3498","journal-title":"Cancer Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"Wood L.D.","year":"2022","unstructured":"Wood L.D.; Canto M.I.; Jaffee E.M.; Simeone D.M.; Pancreatic cancer: Pathogenesis, screening, diagnosis, and treatment. Gastroenterology  2022,163(2),386-402.e1","journal-title":"Gastroenterology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/diagnostics11030562","volume":"11","author":"Ushio J.","year":"2021","unstructured":"Ushio J.; Kanno A.; Ikeda E.; Ando K.; Nagai H.; Miwata T.; Kawasaki Y.; Tada Y.; Yokoyama K.; Numao N.; Tamada K.; Lefor A.K.; Yamamoto H.; Pancreatic ductal adenocarcinoma: Epidemiology and risk factors. Diagnostics  2021,11(3),562","journal-title":"Diagnostics"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"Siegel R.L.","year":"2024","unstructured":"Siegel R.L.; Giaquinto A.N.; Jemal A.; Cancer statistics, 2024. CA Cancer J Clin  2024,74(1),12-49","journal-title":"CA Cancer J Clin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/molecules27133994","volume":"27","author":"Arshad M.F.","year":"2022","unstructured":"Arshad M.F.; Alam A.; Alshammari A.A.; Alhazza M.B.; Alzimam I.M.; Alam M.A.; Mustafa G.; Ansari M.S.; Alotaibi A.M.; Alotaibi A.A.; Kumar S.; Asdaq S.M.B.; Imran M.; Deb P.K.; Venugopala K.N.; Jomah S.; Thiazole: A versatile standalone moiety contributing to the development of various drugs and biologically active agents. Molecules  2022,27(13),3994","journal-title":"Molecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ardp.201400073","volume":"347","author":"Zahran M.A.H.","year":"2014","unstructured":"Zahran M.A.H.; Abdin Y.G.; Osman A.M.A.; Gamal-Eldeen A.M.; Talaat R.M.; Pedersen E.B.; Synthesis and evaluation of thalidomide and phthalimide esters as antitumor agents. Arch Pharm (Weinheim)  2014,347(9),642-649","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e10186","DOI":"10.1371\/journal.pone.0010186","volume":"5","author":"Hawtin R.E.","year":"2010","unstructured":"Hawtin R.E.; Stockett D.E.; Byl J.A.W.; McDowell R.S.; Tan N.; Arkin M.R.; Conroy A.; Yang W.; Osheroff N.; Fox J.A.; Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II. PLoS One  2010,5(4),e10186","journal-title":"PLoS One"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"109597","DOI":"10.1016\/j.cbi.2021.109597","volume":"347","author":"Oliveira A.R.","year":"2021","unstructured":"Oliveira A.R.; dos Santos F.A.; Ferreira L.P.L.; Pitta M.G.R.; Silva M.V.O.; Cardoso M.V.O.; Pinto A.F.; Marchand P.; de Melo R\u00eago M.J.B.; Leite A.C.L.; Synthesis, anticancer activity and mechanism of action of new phthalimido-1,3-thiazole derivatives. Chem Biol Interact  2021,347,109597","journal-title":"Chem Biol Interact"},{"key":"ref=12","year":"2019","unstructured":"Annexes CONCEA normative resolution: Studies domestics animals.  2019"},{"key":"ref=13","year":"2019","unstructured":"Strategies - 2019 - National strategy for science, technology and innovation  Available from:   https:\/\/mohesr.gov.eg\/enus\/Documents\/sr_strategy.pdf 2019"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","volume":"14","author":"Lopez J.S.","year":"2017","unstructured":"Lopez J.S.; Banerji U.; Combine and conquer: Challenges for targeted therapy combinations in early phase trials. Nat Rev Clin Oncol  2017,14(1),57-66","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","volume":"381","author":"Kopetz S.","year":"2019","unstructured":"Kopetz S.; Grothey A.; Yaeger R.; Van Cutsem E.; Desai J.; Yoshino T.; Wasan H.; Ciardiello F.; Loupakis F.; Hong Y.S.; Steeghs N.; Guren T.K.; Arkenau H.T.; Garcia-Alfonso P.; Pfeiffer P.; Orlov S.; Lonardi S.; Elez E.; Kim T.W.; Schellens J.H.M.; Guo C.; Krishnan A.; Dekervel J.; Morris V.; Calvo Ferrandiz A.; Tarpgaard L.S.; Braun M.; Gollerkeri A.; Keir C.; Maharry K.; Pickard M.; Christy-Bittel J.; Anderson L.; Sandor V.; Tabernero J.; Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N Engl J Med  2019,381(17),1632-1643","journal-title":"N Engl J Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","volume":"603","author":"Jaaks P.","year":"2022","unstructured":"Jaaks P.; Coker E.A.; Vis D.J.; Edwards O.; Carpenter E.F.; Leto S.M.; Dwane L.; Sassi F.; Lightfoot H.; Barthorpe S.; van der Meer D.; Yang W.; Beck A.; Mironenko T.; Hall C.; Hall J.; Mali I.; Richardson L.; Tolley C.; Morris J.; Thomas F.; Lleshi E.; Aben N.; Benes C.H.; Bertotti A.; Trusolino L.; Wessels L.; Garnett M.J.; Effective drug combinations in breast, colon and pancreatic cancer cells. Nature  2022,603(7899),166-173","journal-title":"Nature"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4155\/fmc.14.20","volume":"6","author":"Zimmermann M.O.","year":"2014","unstructured":"Zimmermann M.O.; Lange A.; Wilcken R.; Cieslik M.B.; Exner T.E.; Joerger A.C.; Koch P.; Boeckler F.M.; Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery. Future Med Chem  2014,6(6),617-639","journal-title":"Future Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"14539","DOI":"10.1021\/acs.jmedchem.2c00951","volume":"65","author":"Dammann M.","year":"2022","unstructured":"Dammann M.; Stahlecker J.; Zimmermann M.O.; Klett T.; Rotzinger K.; Kramer M.; Coles M.; Stehle T.; Boeckler F.M.; Screening of a halogen-enriched fragment library leads to unconventional binding modes. J Med Chem  2022,65(21),14539-14552","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1016\/j.bmcl.2017.06.025","volume":"27","author":"Thapa Magar T.B.","year":"2017","unstructured":"Thapa Magar T.B.; Kadayat T.M.; Lee H.J.; Park S.; Bist G.; Shrestha A.; Kwon Y.; Lee E.S.; 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent. Bioorg Med Chem Lett  2017,27(15),3279-3283","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.phrs.2018.10.021","volume":"139","author":"O\u2019Bryan J.P.","year":"2019","unstructured":"O\u2019Bryan J.P.; Pharmacological targeting of RAS: Recent success with direct inhibitors. Pharmacol Res  2019,139,503-511","journal-title":"Pharmacol Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/ijms20010028","volume":"20","author":"Belluti S.","year":"2018","unstructured":"Belluti S.; Orteca G.; Semeghini V.; Rigillo G.; Parenti F.; Ferrari E.; Imbriano C.; Potent anti-cancer properties of phthalimide-based curcumin derivatives on prostate tumor cells. Int J Mol Sci  2018,20(1),28","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1021\/ml300322n","volume":"4","author":"Zheng S.","year":"2013","unstructured":"Zheng S.; Zhong Q.; Jiang Q.; Mottamal M.; Zhang Q.; Zhu N.; Burow M.E.; Worthylake R.A.; Wang G.; Discovery of a series of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion. ACS Med Chem Lett  2013,4(2),191-196","journal-title":"ACS Med Chem Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/cryst10030171","volume":"10","author":"Aktas A.","year":"2020","unstructured":"Aktas A.; Barut Celepci D.; Gok Y.; Taslimi P.; Akincioglu H.; Gulcin \u0130.; A novel Ag-N-heterocyclic carbene complex bearing the hydroxyethyl ligand: Synthesis, characterization, crystal and spectral structures and bioactivity properties. Crystals  2020,10(3),171","journal-title":"Crystals"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1871520616666160622095406","volume":"17","author":"Tantak P.","year":"2017","unstructured":"Tantak P.; A facile and microwave-assisted rapid synthesis of 2-arylamino-4-(3\u2032-Indolyl)-thiazoles as apoptosis inducing cytotoxic agents. Anticancer Agents Med Chem  2017,17,442-455","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"19382","DOI":"10.1021\/acsomega.9b02789","volume":"4","author":"Nagireddy P.K.R.","year":"2019","unstructured":"Nagireddy P.K.R.; Kommalapati V.K.; Siva Krishna V.; Sriram D.; Tangutur A.D.; Kantevari S.; Imidazo[2,1-b]thiazole-Coupled natural noscapine derivatives as anticancer agents. ACS Omega  2019,4(21),19382-19398","journal-title":"ACS Omega"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"Conroy T.","year":"2011","unstructured":"Conroy T.; Desseigne F.; Ychou M.; Bouch\u00e9 O.; Guimbaud R.; B\u00e9couarn Y.; Adenis A.; Raoul J.L.; Gourgou-Bourgade S.; de la Fouchardi\u00e8re C.; Bennouna J.; Bachet J.B.; Khemissa-Akouz F.; P\u00e9r\u00e9-Verg\u00e9 D.; Delbaldo C.; Assenat E.; Chauffert B.; Michel P.; Montoto-Grillot C.; Ducreux M.; FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med  2011,364(19),1817-1825","journal-title":"N Engl J Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.clinthera.2017.08.015","volume":"39","author":"Saung M.T.","year":"2017","unstructured":"Saung M.T.; Zheng L.; Current standards of chemotherapy for pancreatic cancer. Clin Ther  2017,39(11),2125-2134","journal-title":"Clin Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e0206688","DOI":"10.1371\/journal.pone.0206688","volume":"13","author":"Schlick K.","year":"2018","unstructured":"Schlick K.; Magnes T.; Ratzinger L.; Jaud B.; Weiss L.; Melchardt T.; Greil R.; Egle A.; Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters. PLoS One  2018,13(11),e0206688","journal-title":"PLoS One"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"100975","DOI":"10.1016\/j.neo.2024.100975","volume":"49","author":"van Eijck C.W.F.","year":"2024","unstructured":"van Eijck C.W.F.; Sabroso-Lasa S.; Strijk G.J.; Mustafa D.A.M.; Fellah A.; Koerkamp B.G.; Malats N.; van Eijck C.H.J.; A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy. Neoplasia  2024,49,100975","journal-title":"Neoplasia"},{"key":"ref=30","first-page":"817","volume":"15","author":"McGill M.R.","year":"2016","unstructured":"McGill M.R.; The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J  2016,15,817-828","journal-title":"EXCLI J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"106449","DOI":"10.1016\/j.bioorg.2023.106449","volume":"134","author":"Amin S.","year":"2023","unstructured":"Amin S.; Sheikh K.A.; Iqubal A.; Ahmed Khan M.; Shaquiquzzaman M.; Tasneem S.; Khanna S.; Najmi A.K.; Akhter M.; Haque A.; Anwer T.; Mumtaz Alam M.; Synthesis, in-Silico studies and biological evaluation of pyrimidine based thiazolidinedione derivatives as potential anti-diabetic agent. Bioorg Chem  2023,134,106449","journal-title":"Bioorg Chem"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266351687250309020134","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240435\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266351687250309020134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:56:53Z","timestamp":1764748613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240435\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680266351687250309020134","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}